Delivery Order SPE2DR25D1205-SPE2DR26F0VY1
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $12,376.97 to AmerisourceBergen Drug Corp for ZENPEP DR 25,000 Unit Capsule 100s on October 22, 2025, with an ultimate completion date of October 23, 2025. This firm fixed-price delivery order represents a non-set-aside competitive award to the pharmaceutical distributor's corporate office located in Conshohocken, Pennsylvania. The contract is a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 28, 2025, for 100 capsules of Zenpep DR 40,000 unit strength with a ceiling value of $2,051.40. This is a firm fixed price delivery order with an ultimate completion date of October 29, 2025, and utilizes no set-aside designation. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under...
- The Defense Logistics Agency awarded a delivery order valued at $31,256.47 to AmerisourceBergen Drug Corp for 100,000 units of Zenpep DR 40,000 unit capsules, with completion targeted for September 17, 2025. This firm fixed-price delivery order was competitively awarded without set-aside provisions and represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, which carries a $999,999,999.00 ceiling value and extends through...
- The Defense Logistics Agency awarded a delivery order valued at $5,778.20 to AmerisourceBergen Drug Corp for ZENPEP DR 40,000 Unit Capsule 100s on September 19, 2025, with an ultimate completion date of September 22, 2025. This firm fixed-price delivery order, which was competitively awarded without set-aside provisions, will be performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. ZENPEP is a pancreatic enzyme replacement therapy used to treat pancreatic...
- AmerisourceBergen Drug Corp was awarded a $7,684.70 delivery order contract by the Defense Logistics Agency (DLA) on September 25, 2025, for the supply of Zenpep DR 60,000 Unit Capsules in quantities of 100 units. The contract, issued under firm fixed pricing with no set-aside designation, has an ultimate completion date of September 26, 2025. Performance will be executed from the awardee's location in Conshohocken, Pennsylvania. This delivery order represents a child contract under...
- The Defense Logistics Agency awarded a $9,447.87 delivery order to AmerisourceBergen Drug Corp for 100 capsule bottles of Zenpep DR 40,000 unit strength. The contract, awarded on August 12, 2025, with an ultimate completion date of August 13, 2025, employs firm fixed price pricing with no set-aside designation, indicating competitive award. Performance will occur at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 22, 2025, for 100 bottles of Zenpep DR 40,000 unit capsules, valued at $3,077.10. This is a firm fixed-price delivery order with no set-aside designation, indicating the award was made through open competition. The contract will be completed by September 23, 2025, and performance will be executed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Zenpep is a pancreatic...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 23, 2025, for ZENPEP DR 40,000 unit capsules (100-count bottles) with a ceiling value of $4,127.11. This firm fixed price delivery order, which achieves ultimate completion on July 24, 2025, represents a competitively awarded non-set-aside contract with performance at the vendor's Conshohocken, Pennsylvania location. ZENPEP is a pancreatic enzyme replacement therapy used to treat pancreatic...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract valued at $2,127.68 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical distributor. The contract is for the delivery of 4,564,242,620 ZENPEP DR 15,000 UNIT CAPSULES 100S, a pharmaceutical product, with a performance period through April 12, 2024. Amerisourcebergen Drug Corp holds an indefinite delivery contract (IDC) with DLA valued at up to...
- The Defense Logistics Agency Troop Support Medical awarded a firm fixed price delivery order valued at ten thousand five hundred ninety-nine dollars and sixteen cents ($10,599.16) to Amerisourcebergen Drug Corporation for Zenpep DR 40,000 unit capsules. Performance will take place at Amerisourcebergen's facility in Conshohocken, Pennsylvania from September 11 through September 12, 2023. The delivery order is placed against an existing indefinite-delivery/indefinite-quantity contract vehicle to...
- SPE2DR25D1205Indefinite Delivery Contract
- SPE2DR25D1205-SPE2DR26F0VY1Delivery Order
The Defense Logistics Agency awarded a $6,797.90 firm fixed price delivery order to AmerisourceBergen Drug Corp for ZENPEP DR 40,000 unit capsules (100-count bottles) on October 29, 2025. This non-set-aside contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The delivery order will be fulfilled at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of October 30, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, serves as a critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems. As a pharmaceutical prime vendor for the DLA Medical Supply Chain, the company provides a comprehensive range of medications and medical supplies across multiple therapeutic domains. This delivery order for ZENPEP, a pancreatic enzyme replacement therapy, exemplifies the company's role in supplying specialized pharmaceutical products to support the Defense Health Agency and other federal healthcare programs through competitive, firm fixed price arrangements.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $6.8k | 10/29/25 |